Metronidazole-13C2,15N2

Metronidazole-13C2,15N2

• CAS Number: 1173020-03-5
• UNSPSC Description: Metronidazole-13C2,15N2 is the 13C-labeled and 15N-labeled Metronidazole. Metronidazole is a nitroimidazole antibiotic medication used particularly for anaerobic bacteria and protozoa.
• Target Antigen: Antibiotic; Apoptosis; Bacterial; Isotope-Labeled Compounds; Parasite
• Type: Isotope-Labeled Compounds
• Related Pathways: Anti-infection;Apoptosis;Others
• Field of Research: Infection
• Assay Protocol: https://www.medchemexpress.com/metronidazole-13c2-15n2.html
• Purity: 99.30
• Solubility: DMSO : 35 mg/mL (ultrasonic;warming)
• Smiles: OCC[15N]1C([N+]([O-])=O)=C[15N]=[13C]1[13CH3]
• Molecular Weight: 175.13
• References & Citations: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. |[2]In Schaechter, M.; Engleberg, N. C.; DiRita, V. J. et al. Schaechter's Mechanisms of Microbial Disease. Hagerstown, MD: Lippincott Williams & Wilkins. p. 28.|[3]http://www.drugs.com/monograph/metronidazole.html|[4]Cohen, S.H., et al., Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol, 2010. 31(5): p. 431-55.
• Shipping Conditions: Blue Ice
• Storage Conditions: -20°C (Powder, sealed storage, away from moisture)
• Clinical Information: No Development Reported